Enhancing collaboration to optimise medication therapy in older adults with cancer: a position paper from SOFOG-SFPO
Hospital Pharmacy Europe
DECEMBER 18, 2023
4,5 Polypharmacy – daily use of five or more drugs – is common in these patients and increases the risk of DRPs, which can result in adverse outcomes such as postoperative complications, chemotherapy toxicities and functional decline. 10,11 This can be due to side effects of chemotherapy or the addition of certain supportive care medications.
96 
Let's personalize your content